← Back to Search

Behavioural Intervention

North Coast Medical Activadose II for Mild Cognitive Impairment (MEMORI Trial)

N/A
Waitlist Available
Led By Vincent Clark, PhD
Research Sponsored by The Mind Research Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within one hour after treatment
Awards & highlights

MEMORI Trial Summary

This trial will determine if transcranial electrical stimulation (tES) can improve memory in healthy older adults, and separately in older adults with mild cognitive impairment or early stage Alzheimer's disease. TES involves applying electrical stimulation to the right temple and left arm for up to 40 minutes.

Eligible Conditions
  • Mild Cognitive Impairment
  • Alzheimer's Disease

MEMORI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within one hour after treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and within one hour after treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Learning Task Performance

MEMORI Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Full Current tESExperimental Treatment1 Intervention
TES delivered with the anode over the right temple and cathode on the left arm, at an intensity of up to 4 milliamps, delivered for up to 40 minutes.
Group II: Partial Current tESPlacebo Group1 Intervention
TES delivered with the anode over the right temple and cathode on the left arm, at an intensity of 0.1 milliamp, delivered for up to 40 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
North Coast Medical Activadose II
2021
N/A
~100

Find a Location

Who is running the clinical trial?

The Mind Research NetworkLead Sponsor
26 Previous Clinical Trials
2,402 Total Patients Enrolled
Vincent Clark, PhDPrincipal InvestigatorUniversity of New Mexico

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being enrolled in this clinical evaluation?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial, which was initially posted on October 7th 2021, is currently recruiting prospective participants. The study needs to enroll 120 individuals from a single medical centre."

Answered by AI

Does this clinical exploration still have vacancies for participants?

"This clinical trial, first posted on October 7th 2021, is actively seeking new participants. The study was recently updated on August 23rd 2022 according to information found at clinicaltrials.gov."

Answered by AI

Does the age requirement for this research project exceed 30 years of age?

"This trial has an age bracket of 50 to 90 years old, with no exceptions."

Answered by AI

Are there any specific criteria for eligibility in this clinical trial?

"To be eligible to join this medical trial, applicants must have Alzheimer's disease and possess an age between 50 and 90. A total of 120 participants are required for the study."

Answered by AI

Who else is applying?

What state do they live in?
New Mexico
What site did they apply to?
Mind Research Network
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I am concerned that I may have memory deficiency and would like to address this.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

What are the possible side effects?
PatientReceived no prior treatments
~28 spots leftby Apr 2025